ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
SZSE:301234
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (2.3), the stock would be worth ¥25.98 (37% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.6 | ¥41.42 |
0%
|
| 3-Year Average | 2.3 | ¥25.98 |
-37%
|
| 5-Year Average | 2.4 | ¥28.09 |
-32%
|
| Industry Average | 2.1 | ¥23.78 |
-43%
|
| Country Average | 1.9 | ¥22.19 |
-46%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
A
|
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
SZSE:301234
|
1.8B CNY | 3.6 | 76 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 13.7 | 37.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 1.3 | 36.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
88.8B DKK | 2.4 | 22.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.8B USD | 2.3 | 31.1 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 0.8 | -16 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 2.1 | 31.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.9B CNY | 5 | 23 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.3B CNY | 1.9 | 21.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.1T KRW | 9.6 | -36.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.9 |
| 70th Percentile | 3.4 |
| Max | 1 129 391.6 |
Other Multiples
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
Glance View
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd, formerly Anhui Hongyu Wuzhou Medical Manufacturer Co Ltd, is a China-based company mainly engaged in the research and development, production and sales of disposable sterile infusion medical devices. The Company is also engaged in the integrated supply of other diagnostic, nursing and other related medical supplies. The Company's main products include syringes, blood infusion sets, medical puncture needles, blood pressure monitors, masks, catheters and other medical supplies related to diagnosis and nursing. Its products are mainly used in clinical injection, blood transfusion and other treatments.